It is a polyphenol-derived small molecule inhibitor of GLUT1, WZB 117 inhibits glucose uptake in multiple tumor cell lines (A172, BHY, HeLa, HN, HT-29, MG-63). Here, SLC2A1 is linked to neoplasm.